Status:
TERMINATED
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
Lead Sponsor:
St. Louis University
Collaborating Sponsors:
Epharmix, Inc.
Conditions:
Short Bowel Syndrome
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The investigators will be using a text messaging intervention to identify potentially dangerous and re- admission causing symptoms in patients with Short Bowel Syndrome (SBS) on Total Parenteral Nutri...
Detailed Description
Short Bowel Syndrome (SBS) is a condition that results from a host of different conditions, the most common of which is Necrotizing Enterocolitis. Patients who have SBS are often Total Parenteral Nutr...
Eligibility Criteria
Inclusion
- Patients under the age of 18
- Patients with a diagnosis of short bowel syndrome and who are treated with total parenteral nutrition
- Patients able to understand English or have a caregiver who understands English.
- Patients must have caregiver who has access to a phone (landline or cell phone)
Exclusion
- Patients who do not have access to a phone (landline or cell phone), and patients who are not mentally able to consent to the study.
- Patients who are not treated with total parenteral nutrition.
- Patients who do no have a short bowel syndrome diagnosis
Key Trial Info
Start Date :
February 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03419156
Start Date
February 20 2018
End Date
March 21 2019
Last Update
March 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardinal Glennon Children's Medical Center
St Louis, Missouri, United States, 63104